Tradestie Institutional Equity Comparison Engine

RGNX vs VYGR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RGNX Overall Edge

RGNX Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to REGENXBIO Inc. (RGNX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while VYGR counters with relative strength in Valuation. Fundamentally, RGNX trades at N/M Forward P/E with -120.4% operating margin (-69.2% YoY revenue) versus VYGR at 8.4x Forward P/E and -436.2% operating margin (-70.0% YoY). In options structure, RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against VYGR sits in BREAKDOWN (31st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VYGR
RGNX N/M vs VYGR 8.4x Fwd P/E
Growth & Margin Winner RGNX
Op Margin -120.4% vs -436.2% ยท YoY -69.2% vs -70.0%
Momentum & Technical Winner RGNX
1Y -35.8% vs -58.2% ยท 52W Pos 19% vs 2%
Options & Structure Winner RGNX
BREAKDOWN (52nd %ile IV) vs BREAKDOWN (31st %ile IV)
RGNX NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.47
-2.23% 1D
Market Cap $500.9M
1M Return +7.87%
1Y Return -35.82%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 36.0 Fund 44.0 Flow 69.0 Mom 50.0
VYGR NASDAQ
Voyager Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.67
-3.76% 1D
Market Cap $102.7M
1M Return -12.37%
1Y Return -58.17%
Forward P/E 8.4x
Unified AI Score
46.3 / 100 HOLD
Tech 40.0 Fund 62.0 Flow 64.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RGNX -35.82% VYGR -58.17% Spread: +22.35 pp (RGNX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period RGNX Revenue VYGR Revenue RGNX Op. Margin VYGR Op. Margin Margin Edge
FY2018 $220M $10M 40.3% -1195.6% RGNX
FY2019 $40M $100M -422.9% -49.5% VYGR
FY2020 $150M $170M -77.1% 16.0% VYGR
FY2021 $470M $40M 34.0% -196.8% RGNX
FY2022 $110M $40M -233.2% -124.3% VYGR
FY2023 $90M $250M -297.1% 48.8% VYGR
FY2024 $80M $80M -280.0% -104.1% VYGR
FY2025 $170M $40M -94.6% -326.6% RGNX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RGNX (5) vs VYGR (5)
Institutional Metric RGNX VYGR Criterion Row Winner
Market Capitalization Scale $500.9M $102.7M Larger Scale RGNX
Trailing P/E Ratio Valuation N/M 8.4x Lower Multiple VYGR
Forward P/E Ratio Valuation N/M 8.4x Lower Multiple VYGR
Revenue Growth (YoY) Growth -69.2% -70.0% Higher Growth RGNX
Operating Margin (TTM) Profitability -120.4% -436.2% Higher Margin RGNX
Net Profit Margin Profitability -113.9% 0.0% Higher Margin VYGR
Return on Equity (ROE) Capital Efficiency -113.2% -58.9% Higher ROE VYGR
52-Week Range Position Momentum 19% ($5โ€“$16) 2% ($2โ€“$5) Stronger Trend RGNX
Beta / 30D Volatility Risk Regime 1.81ฮฒ ยท 76% Vol 1.43ฮฒ ยท 85% Vol Lower Realized Risk RGNX
Unified Institutional Score Composite Signal 45.3 / 100 (HOLD) 46.3 / 100 (HOLD) Higher Composite VYGR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RGNX vs VYGR Buy Guide
RGNX BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VYGR BREAKDOWN
174d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 31st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VYGR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RGNX nor VYGR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.